These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 28073972

  • 1. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
    Gietel-Habets JJ, de Die-Smulders CE, Derks-Smeets IA, Tibben A, Tjan-Heijnen VC, van Golde R, Gomez-Garcia E, Kets CM, van Osch LA.
    Hum Reprod; 2017 Mar 01; 32(3):588-597. PubMed ID: 28073972
    [Abstract] [Full Text] [Related]

  • 2. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA, Gietel-Habets JJ, Tibben A, Tjan-Heijnen VC, Meijer-Hoogeveen M, Geraedts JP, van Golde R, Gomez-Garcia E, van den Bogaart E, van Hooijdonk M, de Die-Smulders CE, van Osch LA.
    Hum Reprod; 2014 May 01; 29(5):1103-12. PubMed ID: 24603131
    [Abstract] [Full Text] [Related]

  • 3. Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors.
    Derks-Smeets IA, de Die-Smulders CE, Mackens S, van Golde R, Paulussen AD, Dreesen J, Tournaye H, Verdyck P, Tjan-Heijnen VC, Meijer-Hoogeveen M, De Greve J, Geraedts J, De Rycke M, Bonduelle M, Verpoest WM.
    Breast Cancer Res Treat; 2014 Jun 01; 145(3):673-81. PubMed ID: 24748567
    [Abstract] [Full Text] [Related]

  • 4. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D, Balmaña J, Graña B, Torres A, Ramón y Cajal T, Darder E, Gadea N, Velasco A, López C, Sanz J, Alonso C, Brunet J.
    Hum Reprod; 2009 Apr 01; 24(4):1000-6. PubMed ID: 19112076
    [Abstract] [Full Text] [Related]

  • 5. Professionals' knowledge, attitude and referral behaviour of preimplantation genetic diagnosis for hereditary breast and ovarian cancer.
    Gietel-Habets JJG, de Die-Smulders CEM, Tjan-Heijnen VCG, Derks-Smeets IAP, van Golde R, Gomez-Garcia E, van Osch LADM.
    Reprod Biomed Online; 2018 Feb 01; 36(2):137-144. PubMed ID: 29242113
    [Abstract] [Full Text] [Related]

  • 6. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.
    Menon U, Harper J, Sharma A, Fraser L, Burnell M, ElMasry K, Rodeck C, Jacobs I.
    Hum Reprod; 2007 Jun 01; 22(6):1573-7. PubMed ID: 17428877
    [Abstract] [Full Text] [Related]

  • 7. Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.
    Woodson AH, Muse KI, Lin H, Jackson M, Mattair DN, Schover L, Woodard T, McKenzie L, Theriault RL, Hortobágyi GN, Arun B, Peterson SK, Profato J, Litton JK.
    Oncologist; 2014 Aug 01; 19(8):797-804. PubMed ID: 24951607
    [Abstract] [Full Text] [Related]

  • 8. Reproductive decision-making in young female carriers of a BRCA mutation.
    Donnelly LS, Watson M, Moynihan C, Bancroft E, Evans DG, Eeles R, Lavery S, Ormondroyd E.
    Hum Reprod; 2013 Apr 01; 28(4):1006-12. PubMed ID: 23293217
    [Abstract] [Full Text] [Related]

  • 9. Recurrent miscarriage in translocation carriers: no differences in clinical characteristics between couples who accept and couples who decline PGD.
    De Krom G, Arens YH, Coonen E, Van Ravenswaaij-Arts CM, Meijer-Hoogeveen M, Evers JL, Van Golde RJ, De Die-Smulders CE.
    Hum Reprod; 2015 Feb 01; 30(2):484-9. PubMed ID: 25432924
    [Abstract] [Full Text] [Related]

  • 10. Support needs of couples with hereditary breast and ovarian cancer during reproductive decision making.
    Gietel-Habets JJG, de Die-Smulders CEM, Derks-Smeets IAP, Tibben A, Tjan-Heijnen VCG, van Golde R, Gomez-Garcia E, van Osch LADM.
    Psychooncology; 2018 Jul 01; 27(7):1795-1801. PubMed ID: 29644780
    [Abstract] [Full Text] [Related]

  • 11. Reproductive Decision-Making in Women with BRCA1/2 Mutations.
    Chan JL, Johnson LNC, Sammel MD, DiGiovanni L, Voong C, Domchek SM, Gracia CR.
    J Genet Couns; 2017 Jun 01; 26(3):594-603. PubMed ID: 27796678
    [Abstract] [Full Text] [Related]

  • 12. BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
    Julian-Reynier C, Fabre R, Coupier I, Stoppa-Lyonnet D, Lasset C, Caron O, Mouret-Fourme E, Berthet P, Faivre L, Frenay M, Gesta P, Gladieff L, Bouhnik AD, Protière C, Noguès C.
    Genet Med; 2012 May 01; 14(5):527-34. PubMed ID: 22241105
    [Abstract] [Full Text] [Related]

  • 13. Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?
    van Tilborg TC, Derks-Smeets IA, Bos AM, Oosterwijk JC, van Golde RJ, de Die-Smulders CE, van der Kolk LE, van Zelst-Stams WA, Velthuizen ME, Hoek A, Eijkemans MJ, Laven JS, Ausems MG, Broekmans FJ.
    Hum Reprod; 2016 Nov 01; 31(11):2651-2659. PubMed ID: 27907901
    [Abstract] [Full Text] [Related]

  • 14. Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.
    Ormondroyd E, Donnelly L, Moynihan C, Savona C, Bancroft E, Evans DG, Eeles R, Lavery S, Watson M.
    Eur J Hum Genet; 2012 Jan 01; 20(1):4-10. PubMed ID: 21811309
    [Abstract] [Full Text] [Related]

  • 15. Knowledge, acceptability and personal attitude toward pre-implantation 1 genetic testing (PGT) and pre-natal diagnosis (PND) for females carrying BRCA pathogenic variant according to fertility preservation experience.
    Dervin T, Ranisavjevic N, Laot L, Mayeur A, Duperier C, Steffann J, Borghese R, Stoppa-Lyonnet D, Frydman N, Benachi A, Sonigo C, Grynberg M.
    J Assist Reprod Genet; 2023 Jun 01; 40(6):1381-1390. PubMed ID: 37154838
    [Abstract] [Full Text] [Related]

  • 16. Professionals assess the acceptability of preimplantation genetic diagnosis and prenatal diagnosis for managing inherited predisposition to cancer.
    Julian-Reynier C, Chabal F, Frebourg T, Lemery D, Noguès C, Puech F, Stoppa-Lyonnet D.
    J Clin Oncol; 2009 Sep 20; 27(27):4475-80. PubMed ID: 19704065
    [Abstract] [Full Text] [Related]

  • 17. Depression, pregnancy-related anxiety and parental-antenatal attachment in couples using preimplantation genetic diagnosis.
    Winter C, Van Acker F, Bonduelle M, Van Berkel K, Belva F, Liebaers I, Nekkebroeck J.
    Hum Reprod; 2016 Jun 20; 31(6):1288-99. PubMed ID: 27106283
    [Abstract] [Full Text] [Related]

  • 18. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
    Phillips KA, Collins IM, Milne RL, McLachlan SA, Friedlander M, Hickey M, Stern C, Hopper JL, Fisher R, Kannemeyer G, Picken S, Smith CD, Kelsey TW, Anderson RA, Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab).
    Hum Reprod; 2016 May 20; 31(5):1126-32. PubMed ID: 27094481
    [Abstract] [Full Text] [Related]

  • 19. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
    Lipton JH, Zargar M, Warner E, Greenblatt EE, Lee E, Chan KKW, Wong WWL.
    Hum Reprod; 2020 Feb 29; 35(2):434-445. PubMed ID: 32099994
    [Abstract] [Full Text] [Related]

  • 20. Comprehensive embryo testing. Experts' opinions regarding future directions: an expert panel study on comprehensive embryo testing.
    Hens K, Dondorp WJ, Geraedts JP, de Wert GM.
    Hum Reprod; 2013 May 29; 28(5):1418-25. PubMed ID: 23416277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.